Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
| Conditions: | Mesothelioma |
| Start Date: | February 1, 2009 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00923455 |
| Study Type: | Interventional |
| Intervention: | Drug: MORAb-009/Drug: Premetrexed/Drug: Cisplatin |
| Study Design: | Treatment/Non-Randomized/Open Label/Active Control/Single Group Assignment/Efficacy Study |
| Results: | No Results Available |
| Sponsors: | National Cancer Institute (NCI) |
| Ages: | Adult/Senior |
| Enrollment: | 16 |
| Funded By: | NIH |
| First Received: | June 17, 2009 |
| End Date: | November 1, 2010 |
| Last Updated: | June 17, 2009 |
| Last Verified: | January 1, 2009 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
